In the originally published article there was an error in Table 1. The reduction in monthly migraine days over 12 weeks versus placebo with quarterly fremanezumab was incorrectly given as “-0.6”; this should read “-3.7”.
Share this Article
Related Content In Headache Disorders
Pre-filled Pen for Anti-calcitonin Gene-related Peptide Migraine Therapy
European Neurological Review. 2020;15(1):11-2 DOI: https://doi.org/10.17925/ENR.2020.15.1.11
Despite the fact that migraine is the most prevalent neurological disorder worldwide, it remains under-diagnosed and under-treated in more than half of all patients.1 In the past decade, the development of monoclonal antibodies capable of blocking either calcitonin gene-related peptide (CGRP) or its receptor have transformed the management of migraine.2 At present, fremanezumab (Ajovy®) is […]
The Upper Nasal Space—A Novel Delivery Route Ideal for Central Nervous System Drugs
US Neurology. 2020:16(1):25–31 DOI: https://doi.org/10.17925/USN.2020.16.1.25
Treatment of acute central nervous system (CNS) conditions requires effective drugs that can provide rapid onset of effect, consistent blood levels, ease-of-use for patient or caregiver, and acceptable tolerability. Solid oral dosage forms account for up to 75% of prescriptions from healthcare providers.1 They are less expensive and easier to manufacture than drug–device combination products, offer […]
Rational Prescribing with an Individualized Approach to Therapy for the Prevention of Migraine
US Neurology. 2020:16(1):15–8 DOI: https://doi.org/10.17925/USN.2020.16.1.15
Although preventive treatment has been a mainstay of migraine treatment for decades, it still remains vastly underutilized.1,2 In recent years, however, the profusion of new treatments for migraine has expanded the therapeutic arsenal for the preventive treatment of migraine. Clinical care pathway for the prevention of migraine John Rothrock When selecting the appropriate preventive therapy, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!